112 related articles for article (PubMed ID: 38375838)
1. Anti-Cancer and Anti-Oxidant Effects of Fenoferin-loaded Human Serum Albumin Nanoparticles Coated with Folic Acid-bound Chitosan.
Almusawi MASK; Pouresmaeil V; Tabrizi MH
Curr Mol Med; 2024 Feb; ():. PubMed ID: 38375838
[TBL] [Abstract][Full Text] [Related]
2. Study the Anticancer Properties of Thymol-Loaded PEGylated Bovine Serum Albumin Nanoparticles Conjugated with Folic Acid.
Al-Salih MYA; Pouresmaeil V; Davoodi-Dehaghani F; Haghighi HN; Tabrizi MH
Chem Biodivers; 2023 Nov; 20(11):e202301122. PubMed ID: 37823866
[TBL] [Abstract][Full Text] [Related]
3. Effects of solid lipid nanocarrier containing methyl urolithin A by coating folate-bound chitosan and evaluation of its anti-cancer activity.
Al-Fatlawi INAA; Pouresmaeil V; Davoodi-Dehaghani F; Pouresmaeil A; Akhtari A; Tabrizi MH
BMC Biotechnol; 2024 Apr; 24(1):18. PubMed ID: 38600497
[TBL] [Abstract][Full Text] [Related]
4. Preparation and Characterization of Allicin-Loaded Solid Lipid Nanoparticles Surface-Functionalized with Folic Acid-Bonded Chitosan:
Alyasiri FJ; Ghobeh M; Tabrizi MH
Front Biosci (Landmark Ed); 2023 Jul; 28(7):135. PubMed ID: 37525919
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of folic acid-conjugated chitosan-coated PLGA nanoparticles for targeted delivery of
Homayouni Tabrizi M
Nanotechnology; 2022 Sep; 33(49):. PubMed ID: 36121718
[TBL] [Abstract][Full Text] [Related]
6. Nanofabrication of PLGA-PEG-chitosan-folic acid systems for delivery of colchicine to HT-29 cancer cells.
Sadeghzadeh F; Ziaratnia AS; Homayouni Tabrizi M; Torshizi GH; Alhajamee M; Khademi D
J Biomater Sci Polym Ed; 2023 Jan; 34(1):1-17. PubMed ID: 35864733
[TBL] [Abstract][Full Text] [Related]
7. Targeted delivery and anticancer effects of Chrysin-loaded chitosan-folic acid coated solid lipid nanoparticles in pancreatic malignant cells.
Farhadi A; Homayouni Tabrizi M; Sadeghi S; Vala D; Khosravi T
J Biomater Sci Polym Ed; 2023 Feb; 34(3):315-333. PubMed ID: 36063019
[TBL] [Abstract][Full Text] [Related]
8. Folic Acid-Conjugated Chitosan-Coated Solid Lipid Nanoparticles: Precision Targeting of Artemisia vulgaris Essential Oils for Anticancer Therapy.
Aghabagherzadeh M; Karimi E; Zareian M
Chem Biodivers; 2024 Jan; 21(1):e202300187. PubMed ID: 38164058
[TBL] [Abstract][Full Text] [Related]
9. PEGylated Lecithin-Chitosan-Folic Acid Nanoparticles as Nanocarriers of Allicin for In Vitro Controlled Release and Anticancer Effects.
Hashemy SI; Amiri H; Hosseini H; Sadeghzadeh F; Jaseem MMM; Tabrizi MH
Appl Biochem Biotechnol; 2023 Jul; 195(7):4036-4052. PubMed ID: 36652093
[TBL] [Abstract][Full Text] [Related]
10. Design and Characterization of a Cancer-Targeted Drug Co-Delivery System Composed of Liposomes and Selenium Nanoparticles.
Xuan G; Zhang M; Chen Y; Huang S; Lee I
J Nanosci Nanotechnol; 2020 Sep; 20(9):5295-5304. PubMed ID: 32331095
[TBL] [Abstract][Full Text] [Related]
11. Fabrication of bovine serum albumin-polyethylene glycol nanoparticle conjugated-folic acid loaded-naringenin as an efficient carrier biomacromolecule for suppression of cancer cells.
Firouzabadi K; Karimi E; Tabrizi MH
Biotechnol Appl Biochem; 2023 Apr; 70(2):790-797. PubMed ID: 36059122
[TBL] [Abstract][Full Text] [Related]
12. Unraveling the Effect of Breast Cancer Patients' Plasma on the Targeting Ability of Folic Acid-Modified Chitosan Nanoparticles.
Nemati M; Bani F; Sepasi T; Zamiri RE; Rasmi Y; Kahroba H; Rahbarghazi R; Sadeghi MR; Wang Y; Zarebkohan A; Gao H
Mol Pharm; 2021 Dec; 18(12):4341-4353. PubMed ID: 34779630
[TBL] [Abstract][Full Text] [Related]
13. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V
Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103
[TBL] [Abstract][Full Text] [Related]
14. Lawsone encapsulated polylactic-co-glycolic acid nanoparticles modified with chitosan-folic acid successfully inhibited cell growth and triggered apoptosis in Panc-1 cancer cells.
Ghafaripour H; Homayouni Tabrizi M; Karimi E; Barati Naeeni N
IET Nanobiotechnol; 2023 Jul; 17(5):425-437. PubMed ID: 37191102
[TBL] [Abstract][Full Text] [Related]
15. The anticancer, anti-oxidant, and antibacterial activities of chitosan-lecithin-coated parthenolide/tyrosol hybrid nanoparticles.
Bahrani HMH; Ghobeh M; Homayouni Tabrizi M
J Biomater Sci Polym Ed; 2023 Aug; 34(11):1603-1617. PubMed ID: 36755525
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells.
Li Q; Liu C; Zhao X; Zu Y; Wang Y; Zhang B; Zhao D; Zhao Q; Su L; Gao Y; Sun B
Int J Nanomedicine; 2011; 6():397-405. PubMed ID: 21499429
[TBL] [Abstract][Full Text] [Related]
17. Effect of folate-targeted Erlotinib loaded human serum albumin nanoparticles on tumor size and survival rate in a rat model of glioblastoma.
Kamali M; Webster TJ; Amani A; Hadjighassem MR; Malekpour MR; Tirgar F; Khosravani M; Adabi M
Life Sci; 2023 Jan; 313():121248. PubMed ID: 36526047
[TBL] [Abstract][Full Text] [Related]
18. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable and biocompatible subcutaneous implants consisted of pH-sensitive mebendazole-loaded/folic acid-targeted chitosan nanoparticles for murine triple-negative breast cancer treatment.
Kefayat A; Hosseini M; Ghahremani F; Jolfaie NA; Rafienia M
J Nanobiotechnology; 2022 Mar; 20(1):169. PubMed ID: 35361226
[TBL] [Abstract][Full Text] [Related]
20. Bifunctional folic acid targeted biopolymer Ag@NMOF nanocomposite [{Zn2 (1,4-bdc) 2 (DABCO)} n] as a novel theranostic agent for molecular imaging of colon cancer by SERS.
Mahboubi F; Mohammadnejad J; Khaleghi S
Heliyon; 2024 Apr; 10(8):e29876. PubMed ID: 38681609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
